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Aims  
Bone tissue engineering (TE) is a multidisciplinary field that aims to repair large bone defects 
by the production of biological spare parts. The focus lies on the design and manufacturing of 
TE constructs that combines several “raw materials” such as carrier structures (scaffolds), 
osteogenic (bone forming) cells and growth factors. Despite the fact that successful results 
have been published, existing bone TE strategies still suffer from unpredictable and 
qualitatively inferior results, thus hampering clinical translation [1, 2]. This low repeatability is 
caused by several factors, including insufficient insight in the 3D mechanisms of in vivo tissue 
formation depending on the TE construct raw materials. Innovations in imaging techniques are 
fundamental to fully understand the complex 3D events during tissue formation. 
In this study, the aim was to investigate the feasibility of using in vivo microfocus X-ray 
computed tomography (in vivo micro-CT) to follow up mineralized tissue formation in TE 
constructs. We present here its potential as well as the constraints for the visualization and 
quantification of the formation of mineralized tissue in different ectopically implanted TE 
constructs in nude mice. 
 
Method 
TE constructs 
To assess the effect of TE construct raw materials on the quality of the in vivo microCT 
datasets, several combinations of these raw materials were evaluated in an ectopic nude 
mouse model at different time points post implantation, ranging between 1 day and 8 weeks. 
Three clinical grade calcium phosphate (CaP)-collagen composite scaffold types with distinct 
differences in CaP and collagen content and structure were used, namely BioOss
®
, NuOss
TM
 
and CopiOs
®
. Scaffolds of different sizes, made from these materials, were coated with a 
growth factor or left uncoated, and subsequently seeded with human periosteal derived cells 
(hPDCs). The constructs were kept in growth medium overnight, allowing cell attachment, and 
implanted subcutaneously on the back of a nude mouse the next morning. 
In vivo and ex vivo micro- and nanoCT  
To determine the scaffold material characteristics and to quantify the morphology, the implants 
were scanned with a Phoenix NanoTom S system [GE, Germany] prior to implantation. The 
isotropic voxelsize was 2.5 µm and the system was equipped with a Diamond/Tungsten target, 
operated at a voltage of 60 kV and a current of 210 µA, a 1mm Al filter was applied and 2400 
images were taken per scan. The exposure time was 500 ms, resulting in a scanning time (in 
fast mode) of 20 minutes. Reconstruction was performed with dedicated software [GE, 
Germany].  
 
In vivo microCT scanning was done at different time points post implantation, ranging between 
1 day and 8 weeks, with a Skyscan 1076 system [Bruker microCT, Kontich, Belgium] at 9 µm 
voxelsize. A 1 mm Al filter was applied with a source voltage of 50 kV and a current of 100 µA. 
The rotation step was 1° and we used a frame averaging of 1. The scan time was about 12 
minutes. To reduce movement of the implant during scanning due to the animal’s breathing 
and heartbeat, we have mounted the mouse on its back in the animal bed of the CT device. 
Reconstruction was performed using NRecon [Bruker microCT, Kontich, Belgium]. 
At week 4 or 8, the animals were sacrificed and the TE constructs were harvested, 
immediately fixed in 4% paraformaldehyde and finally scanned again with the Phoenix 
NanoTom S system, using the same scanning parameters as for the implants, for the 
comparison between the in vivo and ex vivo acquired CT datasets. 
Image processing and analysis, and 3D visualization 
For image processing and analysis, we used CTAn [Bruker microCT, Kontich, Belgium]. 
Regions of interest (ROIs) were manually drawn on the in vivo CT and automatically (using an 
in-house developed MatLab routine) drawn on the ex vivo CT datasets. For the implants, the 
CaP and collagen content, and their thicknesses were determined after multilevel Otsu 
segmentation (3). For the explants and the in vivo microCT datasets, the amount of 
mineralized material was quantified after manual segmentation. CTVox [Bruker microCT, 
Kontich, Belgium] was applied for 3D visualization. 
 
Results 
Influence of the scaffold material and movement on the image quality 
The three scaffold types showed distinct differences in CaP and collagen content, structure 
and distribution (Fig. 1 and 2). CopiOs
®
 contained a low amount (~ 2 volume%) of CaP 
granules, while BioOss
®
 and NuOss
TM
 contained significantly more CaP granules (about 25 
volume% and 15 volume% respectively). 
After implantation, because of the limited mechanical strength, the cylindrical scaffolds are 
compressed, causing a significant decrease in space between the CaP granules. As a result 
of this small space (between 20 µm and 140 µm after implantation) and the limited spatial 
resolution, both for NuOss
TM
 and BioOss
®
 it was not possible to detect newly formed 
mineralized tissue using in vivo microCT (Fig. 3). For CopiOs
®
, the larger space between the 
CaP granules (ranging between 20 and 600 µm) as well as the smaller CaP content allowed to 
visualize the “mineral content”, i.e. both newly formed mineralized tissue and CaP granules. 
No discrimination could be made between the CaP granules and the newly formed mineralized 
tissue (Fig. 3). Hence the scaffold composition and structure strongly influences the 
detectability and image quality of in vivo microCT. 
 
 
Fig.1: A typical cross-sectional reconstructed ex vivo nanoCT image of a BioOss
®
, NuOss
TM
 and CopiOs
®
 
scaffold. The light grey phase (yellow arrow) is the CaP, the darker grey (white arrow) is the collagen 
network. 
  
Fig.2: Ex vivo nanoCT based composition (volume fraction of CaP, collagen and pore space) of the different 
types of scaffold material. Both the CaP and the pore volume fraction were significantly different for the 
three scaffold materials types. 
 
Apart from the scaffold material-related errors in image quality, also sample movement 
introduced image artefacts (Fig. 3 – NuOss
TM
). We tried to limit this by fixing the animal on its 
back during scanning. Again due to the limited space between the CaP granules, for BioOss
®
 
and NuOss
TM
 these movement artefacts were detrimental for the image quality (Fig. 3), while 
for CopiOs
®
 small movements still allowed visualization of the mineral content. 
 
 
Fig.3: Typical in vivo microCT cross-sectional images of a cylindrical BioOss
®
, NuOss
TM
 and CopiOs
®
 
explant after 3 weeks of implantation. 
 
3D quantification of the dynamics of mineralized tissue formation 
Figures 4 and 5B show typical images and the 3D quantification respectively of the mineral 
content present in CopiOs
®
 constructs (using different seeding protocols) during 8 weeks of 
ectopic implantation. A decrease in construct size as well as mineral volume was observed 
(Figs. 4 and 5) after 8 weeks of implantation. Both for construct 1 and 2, however, a clear 
increase in density of the mineral content was seen (Fig. 5). For construct 2, even bone 
spicules were formed after 8 weeks of implantation (confirmed by histology).  
Comparison between the in vivo and ex vivo CT-based visualization (Fig. 6A) and 
quantification (Fig. 6B – n=5) of the same TE construct showed a significant difference in 
mineral content. In vivo microCT overestimated the mineral content, and this error was 
strongly (R² = 0.98) dependent on the volume of the mineral content (labels in Fig. 6B 
represent the overestimation compared to the ex vivo CT results). The lower the amount of 
mineral content present, the larger the relative overestimation was. This was amongst others 
caused by the strong presence of noise in the in vivo microCT images (Fig. 3). 
 
 
      
 
      
  
       
 
 
    
  
Fig.4: Overview of typical cross-sectional in vivo microCT images of 4 different donut-shaped TE constructs 
(different seeding protocols were used), taken at day 1 and after 2, 4, 6 and 8 weeks. 
  
 
Fig. 5: In vivo microCT-based total explant volume and the percentage of mineralized tissue in the total 
explant volume for the 4 different TE constructs (different seeding protocols were used), determined at day 
1 and after 2, 4, 6 and 8 weeks. 
 
Although being on a limited amount of samples, correlating the in vivo and ex vivo CT-based 
results allowed to define a linear equation (Fig. 6B) predicting the ex vivo CT-based 
mineralized tissue volume based on the in vivo CT results. Thus, for future studies, in vivo 
microCT can be used to dynamically follow up the mineral content in ectopically implanted 
CopiOs
®
 constructs.  
In the ex vivo CT images, at early time points of implantation a clear distinction could be made 
between the CaP granules and the newly formed mineralized tissue (Fig. 6A), mainly because 
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the CaP granules did not dissolve or degrade too much. In the in vivo microCT images, this 
was however not possible (Figs. 4 and 6A), hence making 3D quantification of newly formed 
mineralized tissue less accurate. A solution could be to subtract the amount of mineral content 
at day 0 (being CaP granules) from the mineralized tissue volume at consecutive time point 
analyses. As the ex vivo CT results showed CaP granule degradation over time, subtraction of 
the volume of CaP granules at day 0 from the mineral content at consecutive time point 
analyses would not be a solution as atime-dependent underestimation of the mineralized 
tissue volume would be made. 
 
 
Fig.6: (A) Typical 3D visualizations of the in vivo CT and ex vivo CT dataset of the same TE construct 
(CopiOs
®
 coated with a growth factor and seeded with hPDCs) and (B) correlation between the mineralized 
volume measured by ex vivo CT and by in vivo CT of the same TE constructs (n=5). 
 
Conclusion 
Dynamic 3D imaging techniques are becoming more and more important to fully understand 
the complex 3D events during tissue formation. In this study, we investigated the feasibility of 
using in vivo micro-CT to follow up mineralized tissue formation in TE constructs. Several 
parameters influence the accuracy of the in vivo microCT results. Here, it was shown that the 
CaP content and the space between CaP granules play an important role. Given the 
implantation site, movement of the sample could not be eliminated during the imaging; 
however by fixing the animal on the animal bed during scanning it could be strongly limited. 
For TE constructs containing a low amount of small CaP granules, quantitative dynamical 
follow-up of the mineral content in the explant during 8 weeks of implantation could be 
achieved when compensating for mineral volume-dependent errors. Discrimination between 
the CaP granules and the newly formed mineralized tissue was however not possible. 
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